- Home
- VERA vs CLOV Comparison
VERA vs CLOV Comparison
Compare VERA & CLOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERA
- CLOV
- Stock Information
- Founded
- VERA 2016
- CLOV 2014
- Country
- VERA United States
- CLOV United States
- Employees
- VERA N/A
- CLOV N/A
- Industry
- VERA Biotechnology: Pharmaceutical Preparations
- CLOV Medical Specialities
- Sector
- VERA Health Care
- CLOV Health Care
- Exchange
- VERA Nasdaq
- CLOV Nasdaq
- Market Cap
- VERA 1.4B
- CLOV 1.5B
- IPO Year
- VERA 2021
- CLOV N/A
- Fundamental
- Price
- VERA $24.19
- CLOV $2.75
- Analyst Decision
- VERA Buy
- CLOV Strong Buy
- Analyst Count
- VERA 8
- CLOV 3
- Target Price
- VERA $64.29
- CLOV $4.37
- AVG Volume (30 Days)
- VERA 1.8M
- CLOV 5.5M
- Earning Date
- VERA 08-05-2025
- CLOV 11-05-2025
- Dividend Yield
- VERA N/A
- CLOV N/A
- EPS Growth
- VERA N/A
- CLOV N/A
- EPS
- VERA N/A
- CLOV N/A
- Revenue
- VERA N/A
- CLOV $1,607,900,000.00
- Revenue This Year
- VERA N/A
- CLOV $39.93
- Revenue Next Year
- VERA N/A
- CLOV $27.06
- P/E Ratio
- VERA N/A
- CLOV N/A
- Revenue Growth
- VERA N/A
- CLOV 22.12
- 52 Week Low
- VERA $18.53
- CLOV $2.12
- 52 Week High
- VERA $51.61
- CLOV $4.87
- Technical
- Relative Strength Index (RSI)
- VERA 61.33
- CLOV 53.35
- Support Level
- VERA $21.71
- CLOV $2.57
- Resistance Level
- VERA $23.07
- CLOV $2.70
- Average True Range (ATR)
- VERA 1.25
- CLOV 0.10
- MACD
- VERA 0.21
- CLOV 0.03
- Stochastic Oscillator
- VERA 88.89
- CLOV 82.35
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
About CLOV Clover Health Investments Corp.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.